Skip to content

MEDPASYL: what changed

BE 0873.149.458NACE 86.220, Specialist medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€58,397
2024 · -€8,719+€67,116
Equity
€346,190
2024 · €287,793+€58,397
Cash
€257,671
2024 · €17,073+€240,598
Balance sheet total
€373,219
2024 · €357,534+€15,685

Largest movements

2024 to 2025
Assets
  • Cash +€240,598

    up €240,598 (+1,409%), from €17,073 to €257,671

    mainly Current investments (+€223,517) and Investment in fixed assets (net) (+€116,524)

  • Current investments -€223,517

    no longer reported in 2025; in 2024 it stood at €223,517

  • Tangible fixed assets -€116,524

    no longer reported in 2025; in 2024 it stood at €116,524

    of which Land and buildings: -€97,168

  • Receivables within one year +€114,155

    up €114,155 (+27,180%), from €420 to €114,575

    of which Other amounts receivable: +€93,718

Equity and liabilities
  • Reserves +€58,397

    up €58,397 (+94.4%), from €61,860 to €120,257

    of which Distributable reserves: +€58,397

  • Debts after one year -€31,817

    no longer reported in 2025; in 2024 it stood at €31,817

  • Tax, wage and social debts +€25,029

    up €25,029 (+1,251%), from €2,000 to €27,029

  • Current portion of long-term debt -€19,938

    no longer reported in 2025; in 2024 it stood at €19,938

  • Trade debts -€14,518

    no longer reported in 2025; in 2024 it stood at €14,518

Income statement
  • Gross operating margin +€57,568

    up €57,568 (+244%), from €23,614 to €81,182

  • Taxes +€26,501

    up €26,501 (+260%), from €10,198 to €36,699

  • Depreciation -€17,641

    no longer reported in 2025; in 2024 it stood at €17,641

  • Financial income +€16,292

    up €16,292 (+10,511%), from €155 to €16,447

  • Other operating charges -€1,751

    down €1,751 (-84.3%), from €2,076 to €325

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€8,719
Gross operating margin +€57,568
Depreciation +€17,641
Other operating charges +€1,751
Financial income +€16,292
Financial charges +€365
Taxes -€26,501
Result 2025 €58,397
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€47,688
Investment +€340,041
Financing -€51,755
Cash 2024 €17,073
Net result for the year +€58,397
Receivables within one year -€114,155
Deferred charges and accrued income -€974
Trade debts -€14,518
Tax, wage and social debts +€25,029
Other debts -€1,468
Investment in fixed assets (net) +€116,524
Current investments +€223,517
Debts after one year -€31,817
Current portion of long-term debt -€19,938
Contributions, distributions and other +€0
Cash 2025 €257,671
brings cash intakes cash out
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €357,534 €373,219 +€15,685 +4.4%
Fixed assets 21/28 €116,524 - -€116,524
Tangible fixed assets 22/27 €116,524 - -€116,524
Land and buildings 22 €97,168 - -€97,168
Plant, machinery and equipment 23 €12,469 - -€12,469
Furniture and vehicles 24 €6,887 - -€6,887
Current assets 29/58 €241,010 €373,219 +€132,209 +54.9%
Amounts receivable within one year 40/41 €420 €114,575 +€114,155 +27,180%
Trade receivables 40 €420 €20,857 +€20,437 +4,866%
Other amounts receivable 41 - €93,718 +€93,718
Current investments 50/53 €223,517 - -€223,517
Cash at bank and in hand 54/58 €17,073 €257,671 +€240,598 +1,409%
Deferred charges and accrued income 490/1 - €974 +€974
Total equity and liabilities 10/49 €357,534 €373,219 +€15,685 +4.4%
Equity 10/15 €287,793 €346,190 +€58,397 +20.3%
Contributions 10/11 €6,200 €6,200 = 0.0%
Reserves 13 €61,860 €120,257 +€58,397 +94.4%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Distributable reserves 133 €60,000 €118,397 +€58,397 +97.3%
Profit (loss) carried forward 14 €219,733 €219,733 +€0 0.0%
Amounts payable 17/49 €69,741 €27,029 -€42,712 -61.2%
Amounts payable after more than one year 17 €31,817 - -€31,817
Financial debts 170/4 €31,817 - -€31,817
Amounts payable within one year 42/48 €37,924 €27,029 -€10,895 -28.7%
Current portion of amounts payable after more than one year 42 €19,938 - -€19,938
Trade debts 44 €14,518 - -€14,518
Suppliers 440/4 €14,518 - -€14,518
Taxes, remuneration and social security 45 €2,000 €27,029 +€25,029 +1,251%
Taxes 450/3 €2,000 €27,029 +€25,029 +1,251%
Other amounts payable 47/48 €1,468 - -€1,468
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €17,641 - -€17,641
Other operating charges 640/8 €2,076 €325 -€1,751 -84.3%
Gross operating margin 9900 €23,614 €81,182 +€57,568 +244%
Operating profit (loss) 9901 €3,897 €80,857 +€76,960 +1,975%
Financial income 75/76B €155 €16,447 +€16,292 +10,511%
Recurring financial income 75 €155 €16,447 +€16,292 +10,511%
Financial charges 65/66B €2,573 €2,208 -€365 -14.2%
Recurring financial charges 65 €2,573 €2,208 -€365 -14.2%
Profit (loss) for the period before taxes 9903 €1,479 €95,096 +€93,617 +6,330%
Income taxes 67/77 €10,198 €36,699 +€26,501 +260%
Profit (loss) for the period 9904 -€8,719 €58,397 +€67,116
Profit (loss) for the period to be appropriated 9905 -€8,719 €58,397 +€67,116

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€274,356 to €314,860

Midpoint €291,233 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €346,190
Capitalised earnings €202,521 to €283,530
Indication €274,356 to €314,860

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€346,190
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€346,190

Capitalised earnings

net result for the year (9904)
2025
€58,397
2024
-€8,719
2023
€35,381
2022
€37,152
2021
€16,670
excluding non-recurring income and charges
-€2,125
Average result
€28,353
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€202,521 / €236,275 / €283,530

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.